According to the People's Dispensary for Sick Animals (PDSA) PAW, 2.0 million people in the United Kingdom owned pets between March 2020 to May 2021.
Growing Pet Ownership
According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), 67% of the US households own a pet, which accounts for 90.5 million families.
Increasing Prevalence of Animal Diseases
The increasing prevalence of animal diseases, both in farm animals and companion animals, has had a significant impact on the companion animal diagnostics market. As more animals are affected by diseases, there is a growing need for accurate and timely diagnostic tests to help veterinarians diagnose and treat their patients. Chronic conditions such as diabetes, heart disease, and cancer are becoming more common in dogs and cats, and these conditions require ongoing monitoring and treatment. This has led to an increase in the demand for diagnostic tests such as blood tests, urinalysis, and imaging tests to help veterinarians diagnose and manage these conditions. In addition to chronic diseases, infectious diseases are also a growing concern in the companion animal population. Diseases such as lyme disease, parvovirus, and feline immunodeficiency virus (FIV) are becoming more prevalent and accurate, and timely diagnosis is critical for effective treatment and disease management. This has led to an increase in the demand for rapid diagnostic tests that can provide results quickly, allowing for early treatment and prevention of disease transmission. Furthermore, the rise of antibiotic-resistant bacteria in animals is surging the need for more advanced diagnostic tests, which, in turn, is bolstering the growth of the global companion animal diagnostics market. Accurate and timely diagnosis of bacterial infections is critical to ensure that appropriate antibiotics are used that prevent the spread of antibiotic-resistant strains. This has led to an increase in the demand for advanced diagnostic tests such as polymerase chain reaction (PCR) testing, which can provide rapid and accurate diagnosis of bacterial infections. Therefore, the rising incidence of animal diseases is expected to strengthen the growth of the global companion animal diagnostic market in the coming years.
Technological Advancements
For instance, the use of stem cell therapy to treat conditions such as arthritis and joint pain is becoming increasingly popular in veterinary medicines.
Download Free Sample Report
Recent Developments
- In January 2021, Heska acquired Lacuna Diagnostics, Inc. that allowed the company to expand its capabilities and enter the clinical specialty services space, which included services such as telecytology, telepathology, and telemedicine.
- In 2021, Zomedica Corp., a veterinary health corporation producing point-of-care diagnostics products for dogs and cats, logged the first veterinarian sale of TRUFORMA and officially entered commercialization.
Market Segmentation
Global companion animal diagnostics market is segmented into technology, application, animal type, end user, company, and region. Based on technology, the global companion animal diagnostics market is segmented into clinical biochemistry, clinical chemistry analysis, glucose monitoring, blood gas & electrolyte analysis, immunodiagnostics, hematology, urinalysis, and others. Based on application, the global companion animal diagnostics market is bifurcated into clinical pathology, bacteriology, virology, parasitology, and others. Based on animal type, the global companion animal diagnostics market is segmented into dogs, cats, horses, and others. Based on end user, the global companion animal diagnostics market is divided into veterinary reference laboratories, veterinary hospitals and clinics, point-of-care/in-house testing, research institutes, and universities. In terms of region, the global companion animal diagnostics market is divided into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
Market Players
IDEXX Laboratories, Inc., Zoetis Inc., Virbac, Heska Corporation, Neogen Corporation, Bio-Rad Laboratories, Inc. (U.S.), INDICAL Bioscience GmbH (QIAGEN N.V.), Agrolabo SpA (Italy), ID.vet, and bioMérieux S.A. (France). are some of the major leading players of the global companion animal diagnostics market.
Attribute | Details |
Base Year | 2022 |
Historical Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | Technology Application Animal Type End User Region |
Regional scope | North America; Europe; Asia Pacific; South America; and Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy; South Africa, UAE, Saudi Arabia; Brazil, Argentina, and Colombia |
Key companies profiled | IDEXX Laboratories, Inc., Zoetis Inc., Virbac, Heska Corporation, Neogen Corporation, Bio-Rad Laboratories, Inc. (U.S.), INDICAL Bioscience GmbH (QIAGEN N.V.), Agrolabo SpA (Italy), ID.vet, and bioMérieux S.A. (France) |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |